The Trillion-Dollar Promise to Slow Down

Anthropic priced above its range, opened 34% higher and closed at $97.17. Chip and cloud companies are buying $26 billion alongside the IPO, the seven co-founders were the only existing shareholders who sold, and the CEO vowed not to bend to business or political pressure.

A dark cathedral-like trading hall where seven glowing silicon towers beam light into a radiant crystal core beneath a motionless bronze bell.

At 9:46 this morning, before the first trade on Nasdaq, Dario Amodei stood at the Nasdaq podium and made a promise about slowing down. "We will pace the training and deployment of AI systems, taking as long as is necessary to have confidence that they are safe and will remain under human control," he said, according to TechCrunch's transcript, "[w]e will not bend to either business nor political pressure."

Two hours later the stock opened 34% above its offer price. By the close, Anthropic was worth about $1.28 trillion on its outstanding shares, and about $1.76 trillion fully diluted (my arithmetic).

A week ago I read the prospectus as a design document: the revenue, the compute commitments, the safety disclosures, the governance. This is the follow-up. What changed between the last amendment and the final prospectus, what happened on the first day, and what the deal says about who now has a stake in how fast Anthropic goes. Nothing here is investment advice.

TL;DR

  • Priced above the range. $83.00 a share on Wednesday evening, against a $70–$78 range, for 980 million shares: $81.34 billion. Trading opened today on Nasdaq as ANT at $111.50 and closed at $97.17, up 17.07%.
  • The supply chain bought in. Alongside the IPO, Google, NVIDIA, AMD, Broadcom, Micron, Microsoft and TSMC buy $26.0 billion of non-voting stock at the same price, with no lock-up.
  • Among existing holders, only the founders sold. Each of the seven co-founders sold 3,378,378 shares. The company sold the other 956 million.
  • "Largest IPO ever" needs an asterisk. The base deal beats SpaceX's $75 billion base from June, but not SpaceX's $85.7 billion after its greenshoe, unless Anthropic's own greenshoe is exercised.
  • Control did not move. A founders' entity holds 50.1% of the votes, and the Long-Term Benefit Trust elects a board majority.

The deal in one table

ItemValue
Price$83.00 per Class A share (range was $70–$78)
Shares sold980,000,000: 956,351,354 new, 23,648,646 from the co-founders
Gross IPO proceeds$81,340,000,000
Underwriting discount$550,000,000 ($0.56122 a share); lead banks Goldman Sachs and Morgan Stanley
Greenshoeup to 147,000,000 more new shares within 30 days, no underwriting fee
Concurrent private placement$26.0 billion of non-voting Class N stock at $83
Net proceeds to Anthropicabout $104.8 billion including the placement, or about $117.0 billion with the full greenshoe
Shares outstanding after13,219,642,276
Value at the closeabout $1.28 trillion outstanding, about $1.76 trillion fully diluted (my arithmetic)
TickerANT, Nasdaq Global Select Market; settlement November 20

Source for every row except the value at the close (my arithmetic on the press closing price): the final prospectus (424B4, filed today at 06:05 ET) and the pricing term sheet.

What happened, hour by hour

All times Eastern.

  • Tuesday 06:26. Amendment No. 3 still showed 825 million shares at $70–$78, and now said Anthropic had been "approved to list" on Nasdaq as ANT.
  • Wednesday 10:00. The SEC declared the registration effective.
  • Wednesday 18:42. A short filing registered 178,250,000 more shares: the upsizing.
  • Wednesday 21:33. The pricing term sheet: $83.00, 980 million shares, $81.34 billion.
  • Thursday 06:05. The final prospectus.
  • Thursday 09:46. Amodei's opening-bell speech (NBC's live-blog timestamp).
  • Thursday ~11:48–11:50. First trade at $111.50 out of Nasdaq's opening cross. Sources disagree by two minutes.
  • Thursday 11:49–13:18. A high of $114.99 or $115.10, depending on the data source, then a low of $92.72.
  • Thursday 16:00. Close at $97.17. CNBC counted more than 846 million shares traded, against 522 million on SpaceX's first day; other data sources put it between about 832 and 854 million.
  • Thursday evening. $95.00 in after-hours trading at 18:29, per StockAnalysis.

The backdrop was not kind. NBC reported that the S&P 500, the Nasdaq and the Dow each closed down more than 2%. On that day, giving back half the opening pop still left it 17% up.

What changed since the last amendment

Comparing the final prospectus with Amendment No. 3 (November 17):

  • Price: $83.00, $5 above the top of the range, 6.4% (my arithmetic).
  • New shares: 956,351,354, up from 801,351,354. That is 155 million more, all sold by the company. The founders' secondary sale did not grow.
  • Greenshoe: 147 million shares, up from 123.75 million, and the banks now take no discount on them. Full exercise would add about $12.2 billion (my arithmetic).
  • Net proceeds: about $104.8 billion including the placement, up from the $84.6 billion the earlier amendment estimated at an assumed $74.

The placement total ($26.0 billion) and the governance were already in the earlier filings. The $83 price sets the per-buyer share counts.

Who bought in

This is the part of the deal I find most telling. At the IPO price, the prospectus lists who takes the $26.0 billion of Class N stock:

BuyerShares, approximate value
Google120,481,927 shares, about $10.0 billion
NVIDIA120,481,927 shares, about $10.0 billion
AMD30,120,481 shares, about $2.5 billion
Broadcom12,048,192 shares, about $1.0 billion
Micron12,048,192 shares, about $1.0 billion
Microsoft12,048,192 shares, about $1.0 billion
TSMC6,024,096 shares, about $500 million

Read that as a bill of materials. The prospectus says Anthropic trains and serves on "AWS Trainium, Google TPUs, NVIDIA GPUs, and AMD GPUs". It has a hardware supply agreement with AMD for Helios rack-scale systems, reaches Google TPU capacity through "partnerships with Google and Broadcom" and leased accelerators through Broadcom in March 2026. It names TSMC and Micron as manufacturers of the chips and memory it depends on, and Microsoft's Azure is one of the three major clouds that offer Claude. The companies that design the accelerators, make the memory, fabricate the chips and run the clouds will hold equity in Anthropic once the placement closes.

Google's purchase, the filing says, funds "a portion of its previously committed investment obligations under the Google 2026 NPA": an existing commitment converted at the IPO price, not a new decision made this week. AMD's $2.5 billion likewise counts against its July 2026 equity commitment. Because the dollar amounts were fixed, the higher price means fewer shares: Google's projected holding fell from 1,789,598,269 shares in Amendment No. 3 to 1,774,959,745 now. None of these shares carry a lock-up, and Class N stock has no vote.

The two largest holders are still the cloud partners. After the offering, Amazon holds 1,936,452,353 shares (14.6% of all capital stock) and Google 1,774,959,745 (13.4%), per the final prospectus; CNBC's live blog still showed Amendment No. 3's 14.7% and 13.7%. At today's close, by my arithmetic, those are worth about $188 billion and $172 billion. If Amazon converted all of its notes, it would hold 23.6%.

Who sold, and who can sell

Only the seven co-founders sold in the IPO: Dario Amodei, Daniela Amodei, Tom Brown, Jack Clark, Jared Kaplan, Sam McCandlish and Christopher Olah, 3,378,378 shares each. At $83 that is about $280 million each before fees, by my arithmetic. Dario Amodei still owns 237,259,602 Class A shares after the sale; he sold about 1.4% of his Class A shares (my arithmetic). Of the $81.34 billion raised, about $1.95 billion goes to the founders and about $78.8 billion to the company after the discount. The prospectus also repeats that the co-founders have each pledged 80% of their personal equity to philanthropy.

Most other holders are locked up, on a schedule worth reading because it decides when new supply reaches the market. The final prospectus gives dates:

Earliest sale dateShares that may become available
November 19, 2026 (today)up to 315 million Class A shares held by non-founder directors, officers and current and former employees and consultants
December 15, 2026up to 303 million Class A and Class N shares
January 5, 2027up to 303 million
January 19, 2027up to 353 million
February 2, 2027up to 353 million
Second full trading day after the FY2026 resultsup to 1.7 billion, then further steps

The general lock-up ends at the earlier of 180 days or the second full trading day after the results for the quarter ending March 31, 2027. For the co-founders and certain stockholders who held more than 0.5% of the fully diluted shares before the offering, it is the earlier of 365 days or the second full trading day after the results for the quarter ending September 30, 2027. Goldman Sachs and Morgan Stanley can release holders early. A separate filing registers 121,886,381 employee and director shares for resale. How many employees actually sold today is not public.

Retail investors got less than a fifth. The prospectus says retail allocations, in the US and abroad, "represented less than 20%" of the shares; Bloomberg, as cited by CNBC and Euronews, put it at about 15%, around $12 billion. Bloomberg reported a week ago that the book was said to be about six times oversubscribed. The offering also included public tranches in Australia, Canada, parts of the EEA, Japan, Switzerland and the UK, with a Japanese book-building targeted at $3.0 to $3.5 billion.

The record, with an asterisk

Many headlines today call this the largest IPO in history. It depends on what you count.

  • Base deal: $81.34 billion beats SpaceX's $75 billion base from June. CNBC and CBS both make this comparison.
  • After the greenshoe: SpaceX ended at $85.7 billion after its banks exercised their option, per CNBC. Anthropic's base is below that. If its own 147-million-share greenshoe is exercised in full, it would reach about $93.5 billion (my arithmetic), and the record would be clean.
  • With the private placement: $107.3 billion in total, including the founders' secondary. That is where the "more than $100 billion" headlines come from, but a private placement to seven companies is not IPO proceeds in the usual sense.

The valuation headlines have the same layering. At $83, the 13.2 billion outstanding shares are worth about $1.10 trillion; the "$1.5 trillion" figure is fully diluted, counting options, restricted stock units and convertible notes, about 18.1 billion shares by the prospectus's own table (my arithmetic). At the $111.50 open, fully diluted, it was about $2 trillion (my arithmetic).

Governance as priced

Nothing about governance changed at pricing, and the prospectus still calls Anthropic a "controlled company". As in the earlier filings:

  • Class F, held by a founders' entity, carries 50.1% of the total voting power.
  • Class T, held by the Long-Term Benefit Trust, elects and removes directors who make up a majority of the board.
  • Class A, the shares the public bought today, votes, but Class F's 50.1% outweighs it.
  • Class N, including the suppliers' new stock and Amazon's and Google's stakes, has no vote except where the law requires one.
  • Class E, for employees, votes only on limited matters.

One more piece of the structure ties directly to the share price. Anthropic contributed 846,840,960 Class N shares, 5% of its fully diluted shares as of June 30, to a Public Benefit Fund, and the board may issue up to another 2% each time the stock rises 50% above the previous milestone, starting from the IPO price. By my arithmetic the first milestone is $124.50. Today's high did not reach it.

What they said

  • Dario Amodei at the bell, again per TechCrunch: "There is much work still to be done, and the most difficult safety work lies ahead of us." In Nasdaq's own account: "The advent of machine intelligence is one of the seminal moments in human history, and we have a rare opportunity to shape it for the better." On CNBC, per its live blog: "We always want to under promise and over deliver," and, on financing, "Debt is an instrument that we have available to us."
  • Daniela Amodei, in Nasdaq's account: "More than half of the Fortune 500 use Claude for everything from drug discovery to underwriting, to preventing financial fraud and abuse." On CNBC: "This technology needs you — not your trust, not your use, but your voice."
  • The analysts (as reported by CBS and CNBC unless noted): Dan Ives called it an "A-plus success." Melius rated it a buy with a $155 target ("The leverage here could be insane"). Needham, per TNW, rated it a buy with a $150 target. Altimeter's Brad Gerstner: "This isn't a get-rich-quick scheme." The University of Florida's Jay Ritter: "Both the jump from the offer price and the high volatility are not surprising." CBS also cited a Truist study finding that more than half of 32 of the biggest IPOs fell at least 50% at some point in their first year.

Outside, CNBC reported protesters and a "MisAnthropic Statement" signed by more than 90 academics and AI-safety experts. CNBC reported some arrests; NBC reported none.

The promise and the pressure

This section is my opinion.

The pledge at the bell was not new. In September I wrote about Amodei's case for buying time at the frontier. What is new is the audience. Yesterday the people who could punish Anthropic for going slower were its investors, customers and partners. Today they include anyone with a brokerage account and a quarterly earnings calendar.

The governance is what makes the pledge more than words. Public shareholders cannot outvote the founders' entity or replace the trust's directors. The first day showed the market is willing to value a company it cannot control at more than a trillion dollars.

But look at who else is on the cap table. NVIDIA, AMD, Broadcom, Micron and TSMC make money when frontier labs buy more compute, sooner. Google, Microsoft and Amazon sell that compute. None of them has a vote, but they have contracts, supply allocations and roadmaps, and seven of them are taking $26 billion of equity that gains when Anthropic grows fast. Even the Public Benefit Fund can grow each time the stock jumps 50%. None of that contradicts the pledge, but it all pulls toward speed.

My read: the test will not come at a 17% pop on day one. It will come the first quarter Anthropic slows a release for safety reasons while a competitor ships, the stock drops, and a lock-up release is a few weeks away. That is when we will find out whether the share classes can protect "we will not bend."

What to watch

  • November 20: settlement of the IPO, per the pricing term sheet, with the concurrent placement expected to close alongside it.
  • By December 18: the end of the 30-day greenshoe window (my count from the November 18 prospectus date). A full exercise adds about $12.2 billion and settles the record question.
  • December 15, January 5, January 19 and February 2: the staged lock-up releases in the table above.
  • The FY2026 annual results: from the second full trading day after them, up to 1.7 billion more shares may become available, including up to 35% more of employees' stock.
  • May 17, 2027 at the latest: the general lock-up ends (180 days, my count), or earlier, after the results for the quarter ending March 31, 2027.
  • $124.50: the first price at which the Public Benefit Fund can receive up to another 2%.
  • The first earnings call: the first time Anthropic will be questioned on pacing in front of public shareholders.